Mosaic ImmunoEngineering, Inc.
CPMV
$0.65
-$0.1057-13.99%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 695.80K | 787.50K | 867.60K | 883.90K | 964.30K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 879.70K | 1.01M | 1.13M | 1.21M | 1.40M |
| Operating Income | -879.70K | -1.01M | -1.13M | -1.21M | -1.40M |
| Income Before Tax | -919.50K | -1.06M | -1.21M | -897.70K | -1.01M |
| Income Tax Expenses | 2.40K | 0.00 | 0.00 | 0.00 | 2.40K |
| Earnings from Continuing Operations | -0.92 | -1.06 | -1.21 | -0.90 | -1.01 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -921.90K | -1.06M | -1.21M | -897.70K | -1.01M |
| EBIT | -879.70K | -1.01M | -1.13M | -1.21M | -1.40M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.13 | -0.15 | -0.17 | -0.12 | -0.14 |
| Normalized Basic EPS | -0.08 | -0.09 | -0.10 | -0.11 | -0.12 |
| EPS Diluted | -0.13 | -0.15 | -0.17 | -0.13 | -0.14 |
| Normalized Diluted EPS | -0.08 | -0.09 | -0.10 | -0.10 | -0.12 |
| Average Basic Shares Outstanding | 28.95M | 28.95M | 28.95M | 28.95M | 28.95M |
| Average Diluted Shares Outstanding | 28.95M | 28.95M | 28.95M | 30.28M | 30.28M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |